Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Corporate Presentation dated August 13, 2024 ───────────────────────────────────────────────────────────────────────────────── 104 Cover Page to this Current Report on Form 8-K in Inline XBRL SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Arcturus Therapeutics Holdings Inc. Date: August 13, 2024 By: /s/ Joseph E. Payne Name: Joseph E. Payne Title: Chief Executive Officer